Navigation Links
Amylin Pharmaceuticals Reports First Quarter Financial Results
Date:4/18/2011

achieve this goal."

Highlights of Amylin's First Quarter and Recent ActivitiesExenatide

  • Initiated a thorough QT study to address questions raised by the U.S. Food and Drug Administration (FDA) in their complete response letter regarding the BYDUREON™ (exenatide extended-release for injectable suspension) New Drug Application.
  • Announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of BYDUREON in the European Union for the treatment of type 2 diabetes in combination with certain oral therapies.
  • Communicated top-line results from DURATION-6, the sixth DURATION study that showed weekly BYDUREON significantly improved glucose control from baseline. These results reinforce the important role of GLP-1 receptor agonists in the treatment of type 2 diabetes, although BYDUREON did not meet the pre-specified primary endpoint of non-inferiority to daily Victoza® (liraglutide (rDNA origin) injection) in this study.
  • Announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes. The investigational GLP-1 treatment improved glucose control with just one dose per month. After 20 weeks of treatment (five injections), patients randomized to the exenatide once monthly treatment arms experienced average reductions in A1C ranging between 1.3 and 1.5 percentage points from baseline. We are proceeding with regulatory interactions to outline the next steps for this important program within the exenatide franchise.
  • Lilly received approval in Mexico for an expanded indication of BYETTA® (exenatide) injection as an add-on therapy to basal insulin.

  • Obesity Program

  • Voluntarily suspended clinical activities in an ongoing phase 2 study of pramlintide/m
    '/>"/>

  • SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
    2. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
    3. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    4. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
    5. Amylin Pharmaceuticals Reports 2010 Financial Results
    6. Amylin Pharmaceuticals to Webcast Year-End Financial Results
    7. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
    8. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
    9. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    10. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
    11. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company ... for the treatment of cancer and diseases of the ... from three of its most advanced oncology programs at ... th Annual Meeting being held from April 18-22, ... The presentation on the BNC105 program ...
    (Date:4/16/2015)... Mindray Medical International Limited (NYSE: MR ... medical devices worldwide, announced today that it has ... Report on Form 20-F that included audited financial ... electronic version of Mindray,s Annual Report on Form ... at  http://ir.mindray.com  or  http://www.sec.gov . Investors ...
    (Date:4/16/2015)... Calif. , April 16, 2015  Alexza Pharmaceuticals, Inc. ... quarter ended March 31, 2015 on Wednesday, May 6, 2015, ... will also host an investor conference call and live webcast ... provide a company update and discuss the financial results.  ... to www.alexza.com , under the "Investors" link.  Please log ...
    Breaking Medicine Technology:Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
    ... 2011 Cephalon, Inc. (Nasdaq: CEPH ) ... today announced that the companies have signed an agreement ... Alba,s assets relating to larazotide acetate, a tight junction ... the treatment of celiac disease. Under the terms of ...
    ... (NYSE Amex: CUR ) announced that the U.S. ... granted it orphan drug designation for the treatment of Amyotrophic ... stem cells (NSI-566RSC), currently in a Phase I safety study ... route of administration in a wide range of ALS patients. ...
    Cached Medicine Technology:Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics 2Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics 3Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics 4Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS 2Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS 3
    (Date:4/18/2015)... Carinsurancehints.com has released a new blog post explaining how to ... against fire damage. , Clients can now find auto ... is set intentionally on fire. This type of damages can ... things. , It is possible to compare the best ... , in just a few minutes. Clients should always ...
    (Date:4/18/2015)... April 18, 2015 Lowcostcarinsuranceprice.com has released ... rates have on auto insurance prices . ... rates of vehicle theft may have to pay more ... liability auto insurance policies can also offer protection against ... now be compared online on a single website: ...
    (Date:4/18/2015)... More than 2000 styles of newly designed prom ... online store carrying celebrity inspired special occasion dresses. With ... perfect dresses for their prom. For those who are ... TheCelebrityDresses.com would be an ideal choice. , "We ... inspired by the most loved styles seen at this ...
    (Date:4/18/2015)... 2015 French physician and gastronome Anthelme ... when he uttered, “Tell me what you eat, and ... to cope with stress or sadness has often been ... indicates otherwise. Data collected from their Emotional Eating ... emotional eating, but for different reasons. , Collecting data ...
    (Date:4/17/2015)... 2015 Riviera Magazine has ... of the Gallery of Cosmetic Surgery in Newport ... experts. The publication focused on his expertise in ... fat grafting, eyelid surgery, laser resurfacing and rhinoplasty. , ... has resulted in thousands of satisfied patients across ...
    Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3
    ... Bandana, Dog Owners Get an Opportunity to ... DENVER, June 16 Camp Bow Wow, the ... launched a fund raising,effort on behalf of Morris Animal ... dog cancer,and fight other major dog diseases. Beginning June ...
    ... Get a Campaign Bandana, Dog Owners Get an ... and other Diseases, DENVER, June 16 Camp ... overnight camp, has launched a fund raising,effort on behalf ... campaign to cure dog cancer,and fight other major dog ...
    ... Minn., June 16 The Blue Cross and ... grants under two,initiatives designed to improve the health ... Up Healthy: Kids and Communities, $373,000,for Healthy Together: ... grants., Growing Up Healthy, a 10-year funding ...
    ... June 16 Essilor,and the Swiss company Schweiter ... share purchase agreement whereby Essilor will offer to,acquire ... The,agreement is subject to certain conditions precedent, including ... The acquisition,could be completed in the second half ...
    ... can control their disease for years yet avoid insulin ... a new study found. The results were presented Sunday, ... in San Francisco. , Findings from the study ... investigator Arthur Swislocki, MD, of the Veterans Affairs (VA) ...
    ... with thumbs on hand-held devices, , , SUNDAY, June 15 (HealthDay ... without a cell phone in hand, texting for hours at ... folks attempts to spend the day e-mailing, instant messaging and ... -- such as "Blackberry thumb" -- are much more likely ...
    Cached Medicine News:Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow in Indianapolis is Participating 2Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in Michigan Participating 2Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 2Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 3Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 4Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 5Health News:Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions 2Health News:Some patients may not need insulin for long-term control of type 2 diabetes 2Health News: Beware the 'Blackberry Thumb' 2Health News: Beware the 'Blackberry Thumb' 3
    ... designed to accept rigid fixation ... an excellent reconstructive option for ... blowout defects. Each design has ... one or more rigid fixation ...
    Medpor Complete Orbit are designed to replace non load bearing bony structures in the orbital area....
    ... Medpor Inferior Orbital Rim implant can provide ... is designed to be trimmed to meet ... small flange allows it to rest on ... floor. This flange allows easier positioning of ...
    The new Inferior Medial Orbital Rim Implant (IMORI) provides surgeons with an excellent alternative for patients with a deficient or recessed "tear trough" area often characterized as a look of fatig...
    Medicine Products: